Pharma Pulse 7/29/24: Why the Multimodal Data is Growing in Pharma, Specialty Drug Trend Continues Upward & more

Why Multimodal Data is Growing in Pharma

Making connections between different datasets is essential to developing impactful medicines and driving more personalized patient care.

PSG: Specialty Drug Trend Continues Upward

Higher costs per claim, coupled with an increased number of patients using specialty drugs, has contributed to higher spend.

OpenAI Is Launching Search Engine, Taking Direct Aim at Google

Built with input from publishers, SearchGPT will summarize real-time information on websites.

Merck Receives Positive EU CHMP Opinion for KEYTRUDA®

Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv), an antibody-drug conjugate, for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma.

Jaideep Kapoor on LinkedIn

Matt nice informative interview! Good job.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs